Inflammation
Showing NaN - NaN of 5
Heart Failure, Inflammation Trial in Dallas (Low Dose Colchicine, Placebo)
Not yet recruiting
- Heart Failure
- Inflammation
- Low Dose Colchicine
- Placebo
-
Dallas, TexasUT Southwestern Medical Center
Nov 11, 2023
Cardiovascular Risk, Chronic Kidney Disease, Inflammation Trial in Worldwide (Ziltivekimab, Placebo (ziltivekimab))
Recruiting
- Cardiovascular Risk
- +2 more
- Ziltivekimab
- Placebo (ziltivekimab)
-
Birmingham, Alabama
- +768 more
Dec 23, 2022
Chronic Kidney Diseases, Inflammation Trial in United States (Ziltivekimab)
Completed
- Chronic Kidney Diseases
- Inflammation
- Ziltivekimab
-
Birmingham, Alabama
- +48 more
Jul 6, 2021
Inflammation, Systemic Lupus Erythematosus (SLE) Trial in United States (AGS-009, )
Completed
- Inflammation
- Systemic Lupus Erythematosus (SLE)
- AGS-009
- placebo
-
Birmingham, Alabama
- +5 more
Jan 26, 2012